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Nephropathia epidemica (NE) is a mild form of hemorrhagic fever with 
renal syndrome, assumed to have a favorable prognosis. NE patients 
who manifested a higher glomerular filtration rate and mean systolic 
blood pressure, and more proteinuria, versus controls at 5 years 
of follow-up demonstrated no major abnormalities after 10 years. 
Antihypertensive treatment was, however, more common. Could NE 
predispose some patients to develop hypertension after all?
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Puumala (PUU) virus-induced nephro-
pathy in the form of NE occurs in north-
ern parts of Scandinavia, Finland, and 
Russia, and in parts of Central and West-
ern Europe. Th e virus is a member of the 
genus Hantavirus in the Bunyaviridae 
family, and its natural host is the bank vole 
(Clethrionomys glareolus). Over the past 
decades, hantavirus infection has attained 
an increased interest, and a review on the 
topic was recently published.1
Nephropathia epidemica (NE) is char-
acterized by sudden onset with high fever, 
headache, backache, and abdominal pain 
and transient early thrombocytopenia, not 
infrequently in conjunction with conjunc-
tival hemorrhages, palatine petechiae, and 
truncal petechial rash. Th e hemorrhages 
are accompanied by oliguria, proteinuria, 
and hematuria. Within 3 days the rash dis-
appears and the patient develops polyuria. 
Th e typical renal histopathologic lesion is 
acute tubulointerstitial nephritis. Protein-
uria is most commonly due to a loss of 
albumin, refl ecting glomerular injury, but 
concomitant tubular proteinuria refl ected 
by increasing excretion of protein HC (α1-
microglobulin) and β2-microglobulin 
indicates that tubular injury also contrib-
utes to the proteinuria. Severe courses 
of NE with acute renal failure and lethal 
outcome are very rare (<1%). Th e conva-
lescent phase usually lasts from 3 weeks 
to 3 months.
The pathophysiology of hantavirus 
infection derives from the virus’ replica-
tion in macrophages and vascular endo-
thelial cells, especially those in the lung 
and in the kidney, resulting in severely 
increased endothelial permeability. Th e 
main structural protein of the virus is 
the nucleocapsid protein. For pathogenic 
hantaviruses, the entry into host cells 
occurs by attachment to αvβ3 integrin 
on the cellular surface and subsequent 
endocytosis, whereby nucleocapsids are 
released into the cytoplasm. Crucial in the 
pathophysiology of hantavirus infection 
is the increased endothelial permeability 
induced by various cytokines/chemokines 
(tumor necrosis factor-α, interferon-γ, 
interleukin-6, and others). Also, the inter-
action with αvβ3 integrin molecules seems 
to result in defective endothelial perme-
ability regulation.2
Th e long-term prognosis of NE is usu-
ally considered favorable. A series of 
46 patients in Tampere, who had gone 
through NE 3–7 years previously, mani-
fested a higher glomerular fi ltration rate 
and fi ltration fraction, more proteinuria, 
and a higher mean ambulatory systolic 
blood pressure as compared with 38 
healthy seronegative control subjects.3 In a 
study conducted aft er the Korean War, two 
of 13 patients with previous hemorrhagic 
fever with renal syndrome had hyperten-
sive vascular disease.4 Furthermore, in a 
large epidemiological survey from Balti-
more, there was an association between a 
previous infection with rat-borne Seoul-
like hantavirus and an increased risk of 
hypertensive renal disease.5 By contrast, 
a Swedish study did not demonstrate 
any differences in office blood pres-
sure between 110 PUU virus antibody-
positive and 682 antibody-negative indi-
viduals.6 However, in this material there 
was a signifi cant correlation between PUU 
antibody positivity and hypertension in 
individuals older than 60 years of age.
A 10-year follow-up study of the Tam-
pere material3 represents the hitherto 
largest prospective clinical follow-up trial 
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of the eff ects of NE on blood pressure in 
the long term.7 Although NE patients at 
5 years had a higher prevalence of hyper-
tension than controls, the diff erence at 
10 years was no longer signifi cant. Also, 
the slight glomerular hyperfi ltration and 
proteinuria present at 5 years had dis-
appeared during the follow-up period. 
It should be noted, though, that some 
patients and a few controls were on anti-
hypertensive medication, and both groups 
had continued their medication during 
the follow-up. Actually, the blood pressure 
of patients aft er NE remained unchanged 
from 5 to 10 years, whereas the systolic 
blood pressure of controls increased dur-
ing the study period, probably as a refl ec-
tion of ageing. The explanation of this 
somewhat puzzling observation may be 
that the post-NE patients actually were 
more medicated with antihypertensives 
than controls.
Th e glomerular hyperfi ltration 5 years 
aft er acute NE is intriguing, as there are no 
previous reports of this phenomenon aft er 
acute tubular interstitial nephritis. Glo-
merular hyperfi ltration is a known feature 
of early diabetic nephropathy,8 but there 
is also some evidence of (slight) hyperfi l-
tration in early essential hypertension and 
early adult polycystic kidney disease.9,10 
Could the renal microvascular disease 
induced by PUU virus, together with 
the interstitial infl ammatory and tubular 
changes, be instrumental in the induc-
tion of hypertension following NE? Could 
this be of importance for the glomerular 
hyperfi ltration observed at 5 years aft er 
acute NE? Whether this ‘early’ glomeru-
lar hyperfi ltration will eventually lead to a 
decline in glomerular fi ltration rate in the 
long term (aft er decades) is not known. 
At 10 years of follow-up there were obvi-
ously no signs of impaired renal function.7 
However, further follow-up will be needed 
to establish the fi nal outcome of NE.
Th e studies from the Tampere group3,7 
are careful and robust clinical investiga-
tions. However, as in all long-term follow-
up studies, there were dropout problems. 
Ten patients from the NE group and nine 
control subjects dropped out at 10 years. 
As the dropouts did not essentially diff er 
from the study patients (or controls), it 
seems nevertheless safe to conclude that 
the 10-year prognosis of NE is favorable. 
Th at hypertension was no more preva-
lent in post-NE patients than in control 
subjects at 10 years may be attributable to 
the antihypertensive therapy being more 
common in patients than in controls. 
Hence, aft er all, it cannot be excluded 
that NE may predispose some patients to 
develop hypertension.
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